SEC Filing Details
Document Details
Form
Filing Date
Jan 11, 2023
Document Date
Jan 1, 2023
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Aquestive Therapeutics
Issuer
Aquestive Therapeutics, Inc.
Filer
WARGACKI STEPHEN